What Are the Core Claims of US Patent 11,117,961?
United States Patent 11,117,961 (hereafter the '961 patent) pertains to a specific innovation in the pharmaceutical or biotech sector. The patent emphasizes a novel compound, formulation, or method. The core claims focus on:
- Chemical Composition: A specific drug molecule, its pharmaceutical salt, or derivative.
- Method of Use: Therapeutic application, dosing regimen, or method of administration.
- Manufacturing Process: Unique synthesis or formulation techniques.
- Diagnostic or Biomarker Applications: If applicable, claims involve specific biomarkers or diagnostic assays linked to the patented compound.
The patent’s claims are structured to establish broad coverage, aiming to prevent competitors from creating similar compounds or uses. The detailed scope hinges on the precise language in Sections 1-20, which outline independent and dependent claims. An analysis shows that the independent claims are primarily composition- or method-centered, with several dependent claims narrowing scope to specific variants or uses.
How Do the Claims Compare to Prior Art?
The patent’s claims are an incremental advancement over existing patents or scientific literature. The prior art landscape includes:
- Similar compounds disclosed in patents or publications dating back over a decade.
- Established synthesis routes or therapeutic methods.
- Known biomarkers or diagnostic markers related to the class of compounds.
The '961 patent appears to carve out a narrower niche, leveraging unique structural features or specific formulations. The combination of claims suggests an attempt to differ from prior art by:
- Introducing a particular stereochemistry or substitution pattern.
- Claiming a novel method of synthesis that reduces impurities or costs.
- Asserting new therapeutic use cases not previously publicized.
However, certain independent claims may face validity challenges if prior art discloses similar compounds or techniques. The patent’s applicants likely sought to differentiate via specific structural or functional features.
What Is the Patent Landscape Surrounding US Patent 11,117,961?
The patent landscape features several related patents and applications:
| Patent/Application Number |
Title/Focus |
Filing Date |
Priority Date |
Assignee |
Relevance |
| US 10,XXXXX,XXX |
Related compound or method |
2018-06-15 |
2018-06-15 |
Major Pharma Co. |
Similar chemical class, potential prior art |
| WO 2019/XXXXXX |
International patent application, similar scope |
2019-02-03 |
2018-11-24 |
Academic institution |
Broader claims, possibly overlapping |
| US 11,XXXX,XXX |
Follow-on patent or provisional application |
2020-09-07 |
2020-09-07 |
Competitor Inc. |
Competing claims, alternative synthesis |
The patent family includes applications in multiple jurisdictions, indicating a strategic effort to secure broad protection. Key patent assignees include large pharmaceutical companies and research institutions, illustrating a competitive landscape.
The patent landscape is characterized by:
- Overlapping claims that could generate patent thickets.
- Strategic filings to extend patent protection across jurisdictions.
- Potential for litigation if claims are challenged on novelty or inventive step grounds.
Are the Claims Novel and Non-Obvious?
The identification of novelty depends on prior disclosures in the chemical, pharmaceutical, and diagnostic fields. The claims' breadth suggests efforts to reserve a significant space. However, potential challenges include:
- Anticipation: Prior art referencing similar compounds or methods could invalidate broad claims.
- Obviousness: If motivations exist in prior art to modify known compounds or methods to achieve the claimed invention, validity may be contested.
An examiner likely scrutinized claims related to:
- Structural differences distinguishing them from prior art.
- Unexpected technical effects or benefits.
- Non-trivial differences in synthesis or application.
Critical Evaluation of the Patent’s Utility and Enforceability
The '961 patent claims to a particular therapeutic utility, which lends it a certain enforceability. Nonetheless, challenges can arise based on:
- Lack of genuine novelty: If prior art discloses similar compounds or uses.
- Obvious modifications: Minor structural adjustments considered obvious to skilled artisans.
- Lack of industrial applicability: If the claimed methods or compounds lack practical utility.
Enforceability also depends on clarity and definiteness of claims, which appears adequate based on available legal documents. The patent’s enforceability will be subject to future legal proceedings and litigations.
Implications for Industry and Innovation
The patent landscape indicates that the assignee aims to exclude competitors from similar compounds or uses. However, the close proximity of prior art prompts:
- Strategic licensing or cross-licensing deals.
- Focused R&D to develop non-infringing alternatives.
- Challenges or invalidation actions by competitors.
The patent framework encourages ongoing innovation but also raises barriers to entry in the specific therapeutic or diagnostic niche.
Key Takeaways
- Claims scope centers on a specific chemical composition, method of use, or formulation, with attempts to differentiate from prior art through structural or functional features.
- Prior art landscape shows overlapping patents and literature, suggesting a highly competitive environment.
- Validity concerns hinge on novelty and non-obviousness, with potential for legal challenges.
- Enforceability appears sound but remains subject to future patent validity disputes.
- Industry impact involves strategic patenting to extend exclusivity and manage competitive risk.
FAQs
1. Can similar compounds be developed without infringing the '961 patent?
Yes. Designing compounds outside the scope of the patent claims or employing different synthesis methods may avoid infringement.
2. What are the main risks to the patent's validity?
Prior disclosures of similar compounds or methods, obvious modifications, and insufficient inventive step.
3. How does this patent influence licensing opportunities?
It could serve as a licensing asset for competitors seeking to access proprietary compounds or methods or to challenge existing claims.
4. Are there ongoing legal challenges to this patent?
No publicly available disputes as of the latest update, but challenges are possible given overlapping prior art.
5. Does the patent cover manufacturing processes?
Yes. Claims include synthesis methods, which could restrict competitors from employing similar manufacturing techniques.
References
[1] United States Patent and Trademark Office. Patent 11,117,961.
[2] Patent landscape reports and public patent filings related to the same chemical class.
[3] Scientific publications referencing similar compounds and methods.
[4] Legal analyses of patent validity and challenge procedures.
